“The giant GSK breaks the bank to buy the biotech Nuvalent and recover three treatments against lung cancer”

The British pharmaceutical group GlaxoSmithKline will carry out the second largest transaction in its history by purchasing the American Nuvalent for $10.6 billion, notes Isabelle Chaperon, columnist for the “World” Economy department.